GlassScriptPhysician profile
William K Payne
NPI 1902867328
$4,146.00
in general payments reported to CMS, 2019-2025
30 companies · $634 in 2025
The $634 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $559 · 2021: $545 · 2022: $488 · 2023: $319 · 2024: $850 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,802.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $949.19 | 2019-2024 | Alphavent, Inspace, Iconix |
| Ferring Pharmaceuticals INC. | $467.86 | 2019-2025 | Euflexxa |
| Lightbody Medical Technologies INC | $453.55 | 2024-2025 | |
| Depuy Synthes Sales INC. | $378.84 | 2020-2024 | Na, Velys, Dynacord |
| Pacira Therapeutics, INC. | $367.18 | 2019-2021 | |
| Si-Bone, INC. | $210.92 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $185.44 | 2019-2025 | Exparel, Iovera, Zilretta |
| Intellijoint Surgical INC. | $157.75 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $119.95 | 2025 | |
| Spinal Simplicity, LLC | $114.01 | 2024 | Ha Minuteman G3-R |
| Zimmer Biomet Holdings, INC. | $93.28 | 2020-2025 | Tapestry |
| Novo Nordisk INC | $74.45 | 2025 | Wegovy |
| Orthofix Medical, INC. | $70.55 | 2019-2024 | Physio-Stim |
| Endo Pharmaceuticals INC. | $66.78 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $56.99 | 2019-2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $50.00 | 2019-2025 | |
| Pfizer INC. | $47.22 | 2019-2020 | |
| Catalyst Orthoscience | $39.41 | 2021 | |
| Surgalign Spine Technologies, INC. | $30.21 | 2019-2020 | |
| Zimvie INC. | $29.83 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $24.21 | 2019-2021 | |
| Cerapedics INC. | $22.30 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Medacta USA, INC. | $21.00 | 2019 | |
| Kci USA, INC. | $19.76 | 2021 | |
| Linvatec Corporation | $19.29 | 2024 | Biobrace 23mm |
| Bioventus LLC | $16.31 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Fidia Pharma USA INC. | $16.11 | 2019 | |
| Ethicon US, LLC | $15.56 | 2022 | |
| Axogen | $15.37 | 2019 | |
| Kinex Medical Company LLC | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.